Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Small Molecule Services Market: By Product, By Therapeutic Area, By End-User ) and Region Forecast 2020-2031
Severity: Notice
Message: Undefined variable: report_description
Filename: user/report_detail.php
Line Number: 1091
Backtrace:
File: /var/www/precisionbusinessinsights.com/application/views/user/report_detail.php
Line: 1091
Function: _error_handler
File: /var/www/precisionbusinessinsights.com/application/views/user/layout.php
Line: 5
Function: view
File: /var/www/precisionbusinessinsights.com/application/controllers/User.php
Line: 394
Function: view
File: /var/www/precisionbusinessinsights.com/index.php
Line: 315
Function: require_once
Severity: Notice
Message: Undefined variable: report_description
Filename: user/report_detail.php
Line Number: 1099
Backtrace:
File: /var/www/precisionbusinessinsights.com/application/views/user/report_detail.php
Line: 1099
Function: _error_handler
File: /var/www/precisionbusinessinsights.com/application/views/user/layout.php
Line: 5
Function: view
File: /var/www/precisionbusinessinsights.com/application/controllers/User.php
Line: 394
Function: view
File: /var/www/precisionbusinessinsights.com/index.php
Line: 315
Function: require_once
Severity: Notice
Message: Undefined variable: report_description
Filename: user/report_detail.php
Line Number: 1106
Backtrace:
File: /var/www/precisionbusinessinsights.com/application/views/user/report_detail.php
Line: 1106
Function: _error_handler
File: /var/www/precisionbusinessinsights.com/application/views/user/layout.php
Line: 5
Function: view
File: /var/www/precisionbusinessinsights.com/application/controllers/User.php
Line: 394
Function: view
File: /var/www/precisionbusinessinsights.com/index.php
Line: 315
Function: require_once
Severity: Notice
Message: Undefined variable: report_description
Filename: user/report_detail.php
Line Number: 1110
Backtrace:
File: /var/www/precisionbusinessinsights.com/application/views/user/report_detail.php
Line: 1110
Function: _error_handler
File: /var/www/precisionbusinessinsights.com/application/views/user/layout.php
Line: 5
Function: view
File: /var/www/precisionbusinessinsights.com/application/controllers/User.php
Line: 394
Function: view
File: /var/www/precisionbusinessinsights.com/index.php
Line: 315
Function: require_once
Severity: Notice
Message: Undefined variable: report_description
Filename: user/report_detail.php
Line Number: 1114
Backtrace:
File: /var/www/precisionbusinessinsights.com/application/views/user/report_detail.php
Line: 1114
Function: _error_handler
File: /var/www/precisionbusinessinsights.com/application/views/user/layout.php
Line: 5
Function: view
File: /var/www/precisionbusinessinsights.com/application/controllers/User.php
Line: 394
Function: view
File: /var/www/precisionbusinessinsights.com/index.php
Line: 315
Function: require_once
Severity: Notice
Message: Undefined variable: report_description
Filename: user/report_detail.php
Line Number: 1121
Backtrace:
File: /var/www/precisionbusinessinsights.com/application/views/user/report_detail.php
Line: 1121
Function: _error_handler
File: /var/www/precisionbusinessinsights.com/application/views/user/layout.php
Line: 5
Function: view
File: /var/www/precisionbusinessinsights.com/application/controllers/User.php
Line: 394
Function: view
File: /var/www/precisionbusinessinsights.com/index.php
Line: 315
Function: require_once
Severity: Notice
Message: Undefined variable: report_description
Filename: user/report_detail.php
Line Number: 1125
Backtrace:
File: /var/www/precisionbusinessinsights.com/application/views/user/report_detail.php
Line: 1125
Function: _error_handler
File: /var/www/precisionbusinessinsights.com/application/views/user/layout.php
Line: 5
Function: view
File: /var/www/precisionbusinessinsights.com/application/controllers/User.php
Line: 394
Function: view
File: /var/www/precisionbusinessinsights.com/index.php
Line: 315
Function: require_once
Report Benchmarks |
Details |
By Product |
|
By Therapeutic Area |
|
By End-User |
|
Download Free Sample Report
1. Executive summary |
2. Global Small Molecule Services Market Introduction |
2.1. Global Small Molecule Services Market – Taxonomy |
2.2. Global Small Molecule Services Market –Definitions |
2.2.1. By Product |
2.2.2. By Therapeutic Area |
2.2.3. By End-User |
2.2.4. By Region |
3. Global Small Molecule Services Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Small Molecule Services Market Dynamics – Factors Impact Analysis |
3.6. PESTLE Analysis |
3.7. Porter five force Analysis |
3.8. Manufacturing Capabilities and Locations |
3.9. Clients |
3.10. Key Developments |
3.11. Facility Updates and Expansions |
3.12. VC Investments in CDMO Space |
3.13. Foraying into New CDMO Services |
3.14. M&A Analysis |
4. Global Small Molecule Services Market Analysis, 2022 - 2024 and Forecast, 2025 – 2035 |
4.1. Market Analysis, 2022 - 2024 and Forecast, 2025 – 2035 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Small Molecule Services Market Forecast, By Product, 2022 - 2024 and Forecast, 2025 – 2035 |
5.1. API |
5.1.1. Market Analysis, 2022 - 2024 and Forecast, 2025 – 2035 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Finished Dosage Form |
5.2.1. Oral solid dose |
5.2.1.1. Market Analysis, 2022-2024and Forecast, 2025 – 2035 (Revenue, USD Mn) |
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.1.3. Market Opportunity Analysis |
5.2.2. Semi-solid dose |
5.2.2.1. Market Analysis, 2022-2024and Forecast, 2025 – 2035 (Revenue, USD Mn) |
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.2.3. Market Opportunity Analysis |
5.2.3. Parenteral |
5.2.3.1. Market Analysis, 2022-2024and Forecast, 2025 – 2035 (Revenue, USD Mn) |
5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3.3. Market Opportunity Analysis |
5.2.4. Others |
5.2.4.1. Market Analysis, 2022-2024and Forecast, 2025 – 2035 (Revenue, USD Mn) |
5.2.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.4.3. Market Opportunity Analysis |
6. Global Small Molecule Services Market Forecast, By Therapeutic Area, 2022 - 2024 and Forecast, 2025 – 2035 |
6.1. Cardiometabolic Disorders |
6.1.1. Market Analysis, 2022 - 2024 and Forecast, 2025 – 2035 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Oncology |
6.2.1. Market Analysis, 2022 - 2024 and Forecast, 2025 – 2035 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Respiratory |
6.3.1. Market Analysis, 2022 - 2024 and Forecast, 2025 – 2035 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Neurology |
6.4.1. Market Analysis, 2022 - 2024 and Forecast, 2025 – 2035 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Metabolic Disorders |
6.5.1. Market Analysis, 2022 - 2024 and Forecast, 2025 – 2035 (Revenue, USD Mn) |
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Immunology |
6.6.1. Market Analysis, 2022 - 2024 and Forecast, 2025 – 2035 (Revenue, USD Mn) |
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
6.7. Others |
6.7.1. Market Analysis, 2022 - 2024 and Forecast, 2025 – 2035 (Revenue, USD Mn) |
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.7.3. Market Opportunity Analysis |
7. Global Small Molecule Services Market Forecast, By End-User, 2022 - 2024 and Forecast, 2025 – 2035 |
7.1. Pharma and Biopharma |
7.1.1. Small and Start-ups |
7.1.1.1. Market Analysis, 2022-2024and Forecast, 2025 – 2035 (Revenue, USD Mn) |
7.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.1.3. Market Opportunity Analysis |
7.1.2. Mid-Size |
7.1.2.1. Market Analysis, 2022-2024and Forecast, 2025 – 2035 (Revenue, USD Mn) |
7.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.2.3. Market Opportunity Analysis |
7.1.3. Large Companies |
7.1.3.1. Market Analysis, 2022-2024and Forecast, 2025 – 2035 (Revenue, USD Mn) |
7.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3.3. Market Opportunity Analysis |
8. Global Small Molecule Services Market Forecast, By Region, 2022 - 2024 and Forecast, 2025 – 2035 |
8.1. North America |
8.1.1. Market Analysis, 2022 - 2024 and Forecast, 2025 – 2035 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2022 - 2024 and Forecast, 2025 – 2035 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia-Pacific |
8.3.1. Market Analysis, 2022 - 2024 and Forecast, 2025 – 2035 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Latin America |
8.4.1. Market Analysis, 2022 - 2024 and Forecast, 2025 – 2035 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. RoW |
8.5.1. Market Analysis, 2022 - 2024 and Forecast, 2025 – 2035 (Revenue, USD Mn) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
8.6. Global Small Molecule Services Market - Opportunity Analysis Index, By Product, Therapeutic Area, End-User, and Region, 2025 – 2035 |
9. North America Small Molecule Services Market Analysis, 2022 - 2024 and Forecast, 2025 – 2035 |
9.1. Product Analysis (2022 - 2024) and Forecast (2025 – 2035) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. API |
9.1.2. Finished Dosage Form |
9.1.2.1. Oral solid dose |
9.1.2.2. Semi-Solid Dose |
9.1.2.3. Parenteral |
9.1.2.4. Others |
9.2. Therapeutic Area Analysis (2022 - 2024) and Forecast (2025 – 2035) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
9.2.1. Cardiometabolic Disorders |
9.2.2. Oncology |
9.2.3. Respiratory |
9.2.4. Neurology |
9.2.5. Metabolic Disorders |
9.2.6. Immunology |
9.2.7. Others |
9.3. End-User Analysis (2022 - 2024) and Forecast (2025 – 2035) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Pharma and Biopharma |
9.3.1.1. Small and Start-ups |
9.3.1.2. Mid-Size |
9.3.1.3. Large Companies |
9.4. Country Analysis (2022 - 2024) and Forecast (2025 – 2035) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.4.1. U.S. |
9.4.2. Canada |
9.5. North America Small Molecule Services Market - Opportunity Analysis Index, By Product, Therapeutic Area, End-User, and Country, 2025 – 2035 |
9.6. North America Small Molecule Services Market Dynamics – Trends |
10. Europe Small Molecule Services Market Analysis, 2022 - 2024 and Forecast, 2025 – 2035 |
10.1. Product Analysis (2022 - 2024) and Forecast (2025 – 2035) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. API |
10.1.2. Finished Dosage Form |
10.1.2.1. Oral solid dose |
10.1.2.2. Semi-Solid Dose |
10.1.2.3. Parenteral |
10.1.2.4. Others |
10.2. Therapeutic Area Analysis (2022 - 2024) and Forecast (2025 – 2035) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Cardiometabolic Disorders |
10.2.2. Oncology |
10.2.3. Respiratory |
10.2.4. Neurology |
10.2.5. Metabolic Disorders |
10.2.6. Immunology |
10.2.7. Others |
10.3. End-User Analysis (2022 - 2024) and Forecast (2025 – 2035) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Pharma and Biopharma |
10.3.1.1. Small and Start-ups |
10.3.1.2. Mid-Size |
10.3.1.3. Large Companies |
10.4. Country Analysis (2022 - 2024) and Forecast (2025 – 2035) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Germany |
10.4.2. UK |
10.4.3. France |
10.4.4. Spain |
10.4.5. Italy |
10.4.6. Rest of Europe |
10.5. Europe Small Molecule Services Market - By Product, Therapeutic Area, End-User, and Country, 2025 – 2035 |
10.6. Europe Small Molecule Services Market Dynamics – Trends |
11. Asia-Pacific Small Molecule Services Market Analysis, 2022 - 2024 and Forecast, 2025 – 2035 |
11.1. Product Analysis (2022 - 2024) and Forecast (2025 – 2035) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. API |
11.1.2. Finished Dosage Form |
11.1.2.1. Oral solid dose |
11.1.2.2. Semi-Solid Dose |
11.1.2.3. Parenteral |
11.1.2.4. Others |
11.2. Therapeutic Area Analysis (2022 - 2024) and Forecast (2025 – 2035) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Cardiometabolic Disorders |
11.2.2. Oncology |
11.2.3. Respiratory |
11.2.4. Neurology |
11.2.5. Metabolic Disorders |
11.2.6. Immunology |
11.2.7. Others |
11.3. End-User Analysis (2022 - 2024) and Forecast (2025 – 2035) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Pharma and Biopharma |
11.3.1.1. Small and Start-ups |
11.3.1.2. Mid-Size |
11.3.1.3. Large Companies |
11.4. Country Analysis (2022 - 2024) and Forecast (2025 – 2035) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Japan |
11.4.2. China |
11.4.3. India |
11.4.4. ASEAN |
11.4.5. Australia & New Zealand |
11.4.6. Rest of Asia-Pacific |
11.5. Asia-Pacific Small Molecule Services Market - Opportunity Analysis Index, By Product, Therapeutic Area, End-User, and Country, 2025 – 2035 |
11.6. Asia-Pacific Small Molecule Services Market Dynamics – Trends |
12. Latin America Small Molecule Services Market Analysis, 2022 - 2024 and Forecast, 2025 – 2035 |
12.1. Product Analysis (2022 - 2024) and Forecast (2025 – 2035) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. API |
12.1.2. Finished Dosage Form |
12.1.2.1. Oral solid dose |
12.1.2.2. Semi-Solid Dose |
12.1.2.3. Parenteral |
12.1.2.4. Others |
12.2. Therapeutic Area Analysis (2022 - 2024) and Forecast (2025 – 2035) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Cardiometabolic Disorders |
12.2.2. Oncology |
12.2.3. Respiratory |
12.2.4. Neurology |
12.2.5. Metabolic Disorders |
12.2.6. Immunology |
12.2.7. Others |
12.3. End-User Analysis (2022 - 2024) and Forecast (2025 – 2035) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Pharma and Biopharma |
12.3.1.1. Small and Start-ups |
12.3.1.2. Mid-Size |
12.3.1.3. Large Companies |
12.4. Country Analysis (2022 - 2024) and Forecast (2025 – 2035) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Brazil |
12.4.2. Mexico |
12.4.3. Argentina |
12.4.4. Rest of Latin America |
12.5. Latin America Small Molecule Services Market - Opportunity Analysis Index, By Product, Therapeutic Area, End-User, and Country, 2025 – 2035 |
12.6. Latin America Small Molecule Services Market Dynamics – Trends |
13. RoW Small Molecule Services Market Analysis, 2022 - 2024 and Forecast, 2025 – 2035 |
13.1. Product Analysis (2022 - 2024) and Forecast (2025 – 2035) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. API |
13.1.2. Finished Dosage Form |
13.1.2.1. Oral solid dose |
13.1.2.2. Semi-Solid Dose |
13.1.2.3. Parenteral |
13.1.2.4. Others |
13.2. Therapeutic Area Analysis (2022 - 2024) and Forecast (2025 – 2035) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.2.1. Cardiometabolic Disorders |
13.2.2. Oncology |
13.2.3. Respiratory |
13.2.4. Neurology |
13.2.5. Metabolic Disorders |
13.2.6. Immunology |
13.2.7. Others |
13.3. End-User Analysis (2022 - 2024) and Forecast (2025 – 2035) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Pharma and Biopharma |
13.3.1.1. Small and Start-ups |
13.3.1.2. Mid-Size |
13.3.1.3. Large Companies |
13.4. Country Analysis (2022 - 2024) and Forecast (2025 – 2035) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Gulf Cooperation Council (GCC) Countries |
13.4.2. Israel |
13.4.3. South Africa |
13.4.4. Rest of ROW |
13.5. ROW Small Molecule Services Market - Opportunity Analysis Index, Opportunity Analysis Index, By Product, Therapeutic Area, End-User, and Country, 2025 – 2035 |
13.6. ROW Small Molecule Services Market Dynamics – Trends |
14. Competition Landscape |
14.1. Strategic Dashboard of Top Market Players |
14.2. Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
14.2.1. Lonza |
14.2.2. Catalent, Inc |
14.2.3. Patheon Pharma Services |
14.2.4. Cambrex Corporation |
14.2.5. Bellen Chemistry |
14.2.6. Siegfried Holding AG |
14.2.7. Recipharm AB |
14.2.8. Eurofins Scientific |
14.2.9. Aurigene Pharmaceutical Services Ltd. |
14.2.10. CordenPharma International |
14.2.11. Wuxi AppTec |
15. Research Methodology |
16. Key Assumptions and Acronyms |
Key Market Players